China NMPA Inspection - Shanghai Kangmei International Biochemical Co., Ltd. - August 18, 2020

The National Medical Products Administration (NMPA) of China issued an official notification on August 18, 2020, concerning an unannounced inspection of Shanghai Kangmei International Biochemical Co., Ltd. This public announcement, identified by index number JGXX-2020-10001, primarily serves to inform stakeholders about the regulatory oversight conducted by the NMPA. The notification confirms that an unannounced inspection of the named company took place, highlighting the NMPA's commitment to monitoring pharmaceutical and medical product standards. However, the document, published by the NMPA, does not provide specific details regarding the exact dates the inspection occurred. Crucially, the notification refrains from detailing any main violations, issues discovered during the inspection, or specific findings. As a result, no particular regulatory framework infringements or required corrective actions for Shanghai Kangmei International Biochemical Co., Ltd. are outlined within this particular announcement. The document's scope is limited to announcing the regulatory event, without elaborating on its outcomes or any subsequent mandates for the company.